Hemo Organic Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
3.92 Cr.
|
P/BV
|
0.00
|
Book Value (Rs.)
|
-0.15
|
52 Week High/Low (Rs.)
|
12/6
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
30/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -0.16 | -0.18 | -0.14 | -0.01 | -0.03 |
Diluted EPS (Rs.) | -0.16 | -0.18 | -0.14 | -0.01 | -0.03 |
Cash EPS (Rs.) | -0.15 | -0.17 | -0.13 | -0.06 | -0.34 |
Book Value[Excl.RevalReserv]/Share (Rs.) | -0.14 | 0.01 | 0.18 | 0.32 | 0.39 |
Book Value[Incl.RevalReserv]/Share (Rs.) | -0.14 | 0.01 | 0.18 | 0.32 | 0.39 |
Revenue From Operations / Share (Rs.) | 0.01 | 0.01 | 0.02 | 0.79 | 0.15 |
PBDIT / Share (Rs.) | -0.15 | -0.17 | -0.13 | -0.06 | -0.34 |
PBIT / Share (Rs.) | -0.15 | -0.17 | -0.13 | -0.06 | -0.34 |
PBT / Share (Rs.) | -0.15 | -0.17 | -0.13 | -0.06 | -0.34 |
Net Profit / Share (Rs.) | -0.15 | -0.17 | -0.13 | -0.06 | -0.34 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | -1146.20 | -911.62 | -593.22 | -7.87 | -219.71 |
PBIT Margin (%) | -1146.20 | -911.62 | -593.22 | -7.87 | -219.71 |
PBT Margin (%) | -1146.20 | -913.14 | -593.22 | -7.87 | -219.71 |
Net Profit Margin (%) | -1146.20 | -913.14 | -593.22 | -7.87 | -219.71 |
Return on Networth / Equity (%) | 0.00 | -1816.19 | -72.75 | -19.20 | -88.56 |
Return on Capital Employeed (%) | 340.64 | -161.81 | -47.47 | -18.86 | -54.92 |
Return On Assets (%) | -15.88 | -26.08 | -20.51 | -8.83 | -12.60 |
Long Term Debt / Equity (X) | -0.68 | 10.21 | 0.53 | 0.01 | 0.61 |
Total Debt / Equity (X) | -0.68 | 10.21 | 0.53 | 0.01 | 0.61 |
Asset Turnover Ratio (%) | 0.01 | 0.02 | 0.03 | 0.46 | 0.05 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 0.55 | 0.48 | 0.68 | 0.79 | 1.10 |
Quick Ratio (X) | 0.51 | 0.39 | 0.66 | 0.78 | 1.10 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 0.00 | -598.69 | 0.00 | 0.00 | 0.00 |
Interest Coverage Ratio (Post Tax) (%) | 0.00 | -598.69 | 0.00 | 0.00 | 0.00 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 2.38 | 17.81 | 5.08 | 4.00 | 5.68 |
EV / Net Operating Revenue (X) | 498.82 | 2607.01 | 629.69 | 14.41 | 103.92 |
EV / EBITDA (X) | -43.52 | -285.97 | -106.15 | -183.04 | -47.30 |
MarketCap / Net Operating Revenue (X) | 515.89 | 2603.23 | 627.04 | 14.50 | 102.80 |
Price / BV (X) | -48.30 | 5700.00 | 77.25 | 35.47 | 41.54 |
Price / Net Operating Revenue (X) | 546.15 | 2700.00 | 634.78 | 14.52 | 103.18 |
EarningsYield | -0.02 | 0.00 | -0.01 | -0.01 | -0.02 |